Background: There is a need for a quantitative MRI method for iron concentration magnetic resonance imaging suitable for measuring the delivery of targeted superparamagnetic iron oxide nanoparticles (SPIONs) to tumors. Purpose: To apply our newly developed [Fe]MRI method to the quantitative imaging in both space and time of the iron dynamics of anti-prostate specific membrane antigen (PSMA) conjugated SPIONs within human prostate tumor xenografts in nude mice. 
delivery of drugs to tumors could then be studied by first measuring the ratio of iron to drug in the SPIONs and then using the iron concentration in the tumor as a surrogate for the initial drug concentration in the tissue to determine whether the drug actually achieves a therapeutic concentration in the tissue of interest.
However, the nonlinear nature of the effects of SPIONs on water relaxation presents a unique set of challenges with respect to quantitation. SPIONs are primarily transverse relaxation (T 2 , T Ã 2 ) enhancers that produce negative image contrast, but they can also provide positive contrast through longitudinal relaxation (T 1 ) enhancement; the final effect on tissue MRI contrast is a function of the iron concentration in the tissue. By taking both transverse and longitudinal relaxation effects into consideration we have found that for biologically relevant concentrations of SPION iron, in the [Fe] range $1-100 lM, there is a monotonic relationship between iron concentration and the difference between T 1 -weighted and T 2 -weighted MRI contrast. 6 We have used this to develop 6 a general theory of iron-concentration magnetic resonance imaging ([Fe]MRI; pronounced fem-ree), based on specific, SPION-induced, transverse and longitudinal MRI contrast changes for the noninvasive, quantitative molecular MRI of targeted magnetic nanoparticles or other magnetic contrast agents in tumors and other biological sites.
[Fe]MRI can be implemented on the myriad of MRI instruments available around the world because it requires only a small set of easily measured MRI parameters and the acquisition of pairs of T 1 -weighted and T 2 -weighted images.
To use targeted SPIONs for tumor detection by MRI, a tumor cell-surface epitope must be identified that discriminates cancer cells from normal, nonmalignant cells. A large body of research [7] [8] [9] on prostate cancer specific cell markers has led to the identification of prostate specific membrane antigen (PSMA), the folate receptor, as a cell-surface protein highly overexpressed on prostate tumors in a grade and stage dependent manner. For example, aggressive, androgenindependent C4-2 prostate cancer cells 10 make more than one million PSMA molecules per cell 11 making PSMA a good candidate for monitoring the presence and progression of prostate cancer. A humanized antibody to PSMA, J591, has been successfully used to target prostate cancer in clinical trials. 9 We have shown that antibodies to PSMA can be attached to SPIONs that specifically bind to prostate tumor cells 12 and have already used [Fe] MRI to measure the iron concentration, [Fe] , in tumor cell preparations in vitro. 6 Here, we sought to extend these studies to determine whether quantitative [Fe] MRI of PSMA-targeted SPIONs could discriminate among human prostate tumor xenografts in nude mice on the basis of their expression of PSMA.
We also sought to monitor the diffusion, dynamics, and targeting efficacy of these SPIONs and to derive their lifetimes and kinetics in xenografts.
Materials and Methods
Materials MACS V R (lMACs) streptavidin superparamagnetic iron oxide nanoparticles (SPIONs: $50 nm diameter, 57% iron oxide w/w, dextran coating, 1.67 3 10 217 g Fe/nanoparticle) were obtained from Miltenyi Biotec (Bergisch Gladbach, Germany). Fully humanized anti-PSMA antibody J591 was purchased from N. Bander (Weil Cornell Medical College, NY). Anti-PSMA antibody (clone 3C6) was purchased from Northwest Biotherapeutics (Bothell, WA). These antibodies were used interchangeably and were biotinylated using EZ-Link TM Sulfo-NHS-LC-Biotin from Pierce (Rockford, IL)
according to the manufacturer's instructions. LNCaP and DU145 human prostate cancer cell lines were purchased from the American Type Culture Collection (Manassas, VA). The C4-2 prostate cancer cell line was a kind gift from Dr. G.N. Thalmann (University of Bern, Switzerland).
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Iron Assays
Solutions containing SPIONs were dissolved in 0.5 mL of 6 N HCl (Sigma-Aldrich, St. Louis, MO) at 95 8C overnight in sealed tubes. Aliquots (0.1 mL) of the resulting solution were assayed for iron spectrophotometrically using the Ferrozine assay (SigmaAldrich, St. Louis, MO) and reading the absorbance at 562 nm. Standard curves (n 5 7) prepared using 1.00 mM FeCl 3 (SigmaAldrich, St. Louis, MO) gave an extinction coefficient of 27,300 6 971 L/mol-cm. Note that here we use the chemist's notation for the iron concentration as [Fe] .
Cell Culture
Human LNCaP, C4-2, and DU145 prostate cancer cells were cultured in T-medium with 10% fetal calf serum (Hyclone, Logan, UT) 11 at 37 8C in a humidified 5% CO 2 atmosphere. Upon reaching 90% confluency, cells were collected either by detachment in 0.5% trypsin containing 0.02% ethylenediaminetetraacetic acid or detached in cold phosphate buffered saline (PBS; pH 7.41) using cell scrapers. Cells (6.5 3 10 6 ) were concentrated by centrifugation at 5000 3 g for 10 min, and resuspended in 1% matrigel in PBS (100 lL) for sterile injection into the flanks of athymic nude mice (vide infra). Prior studies 11 have shown that LNCaP and C4-2 cells expressed (1.05 6 0.10) 3 10 6 and (1.67 6 0.28) 3 10 6 PSMA molecules per cell, respectively, while DU145 cells expressed 100-fold less at only (1.35 6 0.52) 3 10 4 PSMA molecules per cell.
Subcutaneous xenografts in nude mice used LNCaP and C4-2 cells as PSMA positive samples, and DU145 cells as negative controls based on these measurements in cultured cells. 6 
Antibody Conjugation and SPION Labeling
Sulfo-NHS-LC-Biotin groups were attached to primary amines of MAb 3C6 using the EZ-Link TM Sulfo-NHS-LC-Biotin kit according to the manufacturer's protocol. Conjugated MAb 3C6 was separated from low molecular weight compounds using a Millipore Ultrafree V R -MC Centrifugal Filter Unit at a force of 3000 g in a fixed angle microfuge rotor. Antibody concentration was determined using the Pierce Protein Assay Reagent Kit, and the ratio of biotin/antibody was determined with a Pierce HABA colorimetric assay, both according to the manufacturer's protocol. Later experiments used J591, which was biotinylated using the same method as 3C6 and attached to streptavidin-conjugated SPIONs by incubation for 30 min. The free antibody was removed by washing the beads with the aid of a magnetic bead separation device (Miltenyi, Inc.). The ratio of antibody to SPION was determined from the protein and Fe assays; a typical SPION contained $50 antibody molecules. Control SPIONs were also prepared by omitting the antibody conjugation step.
Animals
Forty-five 5-to 6-week-old athymic nude male mice were purchased from Harlan Sprague Dawley, Inc. (Indianapolis, IN). All animal procedures were approved by our local animal use committee. Tumors were produced by injecting 100 lL of the cell:matrigel mixture (containing 6.5 3 10 6 cells) in PBS subcutaneously into the abdominal flank skin of nude mice. Tumors were allowed to grow while the animals were monitored on a daily basis and the tumor volume was measured weekly with a caliper. The animals were used for MRI when the resulting tumors reached a volume of 
Anesthesia
For the MRI studies, the tumor-bearing mice were anesthetized with 1% isoflurane mixed with oxygen. Preinjection images were obtained to measure the necessary tumor water relaxation times and the relaxation-weighted tumor MR signal backgrounds. Then aliquots of the SPION preparations were either directly injected into the tumors, or into the tail veins of the mice. Time courses of the tumor MR intensities were acquired for durations of up to $2 h, after which the mice were removed from the magnet, allowed to recover, and later reanesthetized for the determination of additional time points. For studies requiring MR scans the next day, the mice were removed from the magnet, allowed to recover overnight, and the next day reanesthetized for the determination of additional time points. For measurement of the dose-response curve for PSMA-conjugated SPIONs the [Fe] in the injections was varied from 0 to $1 mg/mL.
MRI
MRI was carried out using a horizontal bore instrument at 1.0T (MRT Systems, Tsukuba, Japan) with a custom 50 mm diameter 10-turn solenoid coil. All two-dimensional (2D) images were acquired with a 32 mm field of view, a 128 3 128 image matrix, 0.25 mm in-plane resolution, nine slices each 2.5 mm-thick, and number of excitations 5 8. T 2 -weighted (T 2 w) images were acquired using a spin echo (SE) sequence with echo time (TE) 5 23.5 ms and repetition time (TR) 5 1000 ms. T 1 -weighted (T 1 w) images used TR 5 500 ms and TE 5 4 ms. The spin-lattice relaxation time (T 1 ) for tumor water was determined using an inversion-recovery sequence of spin echo images with an TE of 10.7 ms and variable TR ranging from 0.01 to 10 s. Regions of interest (ROIs) were selected corresponding to the psoas muscle and the implanted tumors. The signal intensity S of an ROI was plotted as a function of recovery time TR, and T 1 was determined by a three-parameter fit to the function S(TR) 5 S 1 (1 -P exp(-TR/T 1 )), where S 1 was the fully recovered signal intensity and P was a measure of the level of inversion achieved (P 5 2 for perfect inversion). Using a series of SE images with different TE values, T 2 decay curves were generated for each of the tissue components by selecting an ROI corresponding to each component (psoas muscle and tumor) and plotting the mean signal intensity S of the ROI as a function of TE. T 2 was determined by fitting the decay curves with an exponential, S(TE) 5 S o exp(-TE/T 2 ), where S o is the signal intensity for TE 5 0, and T 2 was the desired time constant.
SPION Relaxivities
The relaxivities of the SPIONs were determined by dissolving them in 1% agarose gels and measuring the water relaxation times (T 1 , T 2 ) for various [Fe] values; these relaxation times were inverted to produce relaxation rate enhancements (R 1 5 1/T 1 , R 2 5 1/T 2 ) which were then plotted as a function of [Fe] . Linear least squares fits to these data gave the relaxivities, r 1 and r 2 as the slopes of the fitted lines.
SPION Diffusion Within Tumors
The SPIONs locally altered the intensity of the tumor's T 1 w MR signal, but did not immediately distribute themselves uniformly within the tumor parenchyma after direct intra-tumoral injection, we were able to monitor the diffusion of the SPIONs away from the injection site. The pixel area of the altered MR signal was converted to real space using the calibrated gradient value of 0.25 mm/ pixel and measured over time in T 1 w images; these areas, A, were then converted to an effective diffusion radius using r 5 Sqrt(A/p) and plotted versus Sqrt(t), where t was the elapsed time after injection. The slope of the resulting linear least squares fit to the data was Sqrt(2D), where D was the diffusion coefficient.
Image Processing
The complex, time-domain MRI datasets were baseline-corrected, Fourier-transformed and co-added using Mathematica version 10.0.2 (Wolfram Research, Urbana, IL) to produce the frequency domain images of each MRI slice. The average and standard deviation of the pixel intensities in the regions of interest within the tumors were measured with ImageJ Software. 12 Qualitative image contrast was judged visually by comparing the intensity of a given region on an MR image with the intensities of other organs or regions (reference regions) and was reported as equal to (isointense) less than (hypointense) or greater than (hyperintense) with respect to the reference region. Quantitative tumor image contrast was defined as C(x, y) 5 [A(x, y) -B(x, y)]/B(x, y), where B(x, y) was the background MR signal intensity from the pixel at (x, y) in the tumor region of interest before the injection of SPIONs, while A(x, y) was the MR signal intensity of the tumor pixel within the same slice after the injection of SPIONs (either directly into the tumor, or by injection into the tail vein). Note that contrast defined here can range from C 5 11 to C 5 -1.0, with positive (negative) contrast indicating that the object of interest was hyperintense (hypointense) with respect to the background, preinjection, signal from the tumor.
Summary of the [Fe]MRI Method
The details of the [Fe]MRI method for the quantitative MR imaging of the added iron concentration in cells are given in reference 6 (q.v.) and are briefly summarized as follows. Pairs of T 1 -weighted and T 2 -weighted MR spin-echo images were converted into contrast images, C 1 and C 2 , and these were subtracted to produce a contrast difference image, DC The [Fe]MRI procedure was as follows:
(1) The r 1 , and r 2 relaxivities of the SPIONs were measured. Here: r 1 5 40.6 6 1.1 Hz/mM and r 2 5 890 6 15.9 Hz/mM (mean 6 SD). (6) Each of these images was converted into contrast maps, C(x,y), using the measured T 1 w, or T 2 w, backgrounds, B 1 (x,y) and B 2 (x,y) producing:
The difference between these two contrast maps was a contrast difference map DC(x,y) 5 C 1 (x,y) -C 2 (x,y) whose intensity was proportional to the Fe concentration, [Fe] 5 g(DC). The function g was calculated in Mathematica V R from the relaxivities, the relaxation times and the acquistion parameters, using our published method 6 as follows: The contrast difference (DC: the green curve in Fig. 2 ) was numerically computed using the equations in Sillerud 6 giving DC as a function of [Fe] as a lM (vide infra) a value which set the lower limit of iron detection with this method. 6 The Mathematica code also served as an essential guide for planning experiments to achieve the optimal sensitivity of contrast to [Fe] . We would be glad to provide this Mathematica notebook to the interested reader by means of email. A technical note to be aware of is the fact that MR images are commonly presented as magnitude data calculated from the acquired complex data sets. The result is that the image noise in otherwise signal-free regions is also presented as magnitude data and hence acquires a positive, nonzero mean. While this is of little concern for most MR imaging applications, its impact here was to produce images of the iron concentration ([Fe]MR images) that appeared to contain a background nonzero [Fe] 
Results
MRI Contrast in C4-2 Xenografts After
Intratumoral Injections of SPIONs MR images of the human C4-2 prostate tumor xenografts, before SPION injection, visually showed the tumors as regions isointense (see the Materials and Methods section) with the psoas muscle in T 1 w images (Fig. 1a) but hyperintense (Fig. 1b) in T 2 w images. Moreover, in both types of MR image the tumors visually appeared uniform in intensity with little pixel to pixel variation in the MR signal. Direct injection of anti-PSMA-conjugated SPIONs containing 0.24 mM iron into the tumor was followed by local alterations in the MR signal in both types of image with an area of hypointensity observed in the T 2 w image (Fig. 1d) and a smaller hypointense area in the T 1 w image (Fig. 1c) . The region of hypointensity in the T 2 w image expanded with time as the SPIONs diffused throughout the tumor (Fig. 1f,h ). On the other hand, the initial hypointense region seen at early times in the T 1 w image (Fig. 1c) became isointense by 177 min (Fig. 1e) and became hyperintense in the T 1 -w image taken 416 min later (Fig. 1g) .
Theoretical Dependence of Contrast on [Fe]
Our theory, using the measured relaxivities of the lMACs SPIONs at 1.0T and the stated acquisition parameters, predicted that the T 2 w image contrast was negative for all the [Fe] values, while the T 1 w image contrast was positive up an [Fe] of $200 lM (Fig. 2) . Note that the contrast difference was always positive, and was a monotonic, increasing function of [Fe] , within the physiological range of iron concentration from 1 to $150 lM.
Measurement of the SPION Diffusion Coefficient
From Boundary Movement A control T 1 w MR image, taken before anti-PSMAconjugated SPION injection, of a mouse bearing a C4-2 tumor xenograft (Fig. 3a) displayed the uniform MR signal intensity distribution seen earlier (Fig. 1a) for these tumors. Intratumoral injection of 20 lL of the SPION preparation containing 0.4 mM iron (Fig. 3b) (Fig. 3 b,c) congruent with our theory (Fig. 2) . By measuring the number of bright pixels in these images and converting the area to a radius using the known gradient calibration (see the Materials and Methods section) the time dependence of the boundary was used determine the SPION diffusion coefficient D 5 44. (Fig. 4d) as both 3D surface plots, using a rust-colored scheme (Mathematica's "SunsetColors" reversed) for mapping [Fe] to color (Fig. 4b,e) , and as 2D plots using the same color scheme (Fig. 4c,f ) . Here, the iron signal was uniformly positive because it was derived from the positive contrast difference between the C 1 and C 2 MR images (see the Materials and Methods section and Fig. 2 , green curve). As the SPIONs were diluted by diffusion into the tumor parenchyma (eg) the initial darkening in the T 1 -w image (c) changed to hyperintensity. In these and subsequent images, the bright circle in the lower left hand corner of (a) and all the other images was from a gadolinium-doped water standard contained in a 1.0 mL syringe. the injected dose) and remained constant for up to a day postinjection.
[Fe]MRI After Tail Vein Injections: Injections of Anti-PSMA Conjugated SPIONs Both single-tumor (Fig. 6a ) and dual-tumor (Fig. 6b) mice (see the Materials and Methods section) were used for tailvein injections. An anatomical spin-echo image taken through the midsection of a mouse in which a LNCaP tumor was grown on one flank and a DU145 (Fig. 6b) on the other showed ( Fig. 6d) both tumors within the same MRI slice. A 3D plot of an [Fe]MR image generated before SPION injection (Fig. 6c) showed that the [Fe] image contained no iron signal, above the background noise, from either tumor. Eleven hours after the administration of anti-PSMA-conjugated SPIONs the [Fe] MR image of this mouse revealed (Fig. 6e ) uptake of these SPIONs by the PSMA-positive LNCaP tumor to a concentration of $100 lM, but essentially no uptake by the PSMA-negative DU145 tumor in the same animal. We confirmed this iron uptake postmortem by excising both tumors and staining them for iron with the result that the LNCaP tumor stained (Fig. 6f ) for iron with Perl's reagent, but the DU145 tumor did not (Fig. 6g) . This optical image of the LNCaP tumor also showed that the SPIONs were taken up by the $12-lm-diameter cells because the cytoplasm stained blue in agreement with the fact that anti-PSMA antibody binding to the PSMA molecule on the tumor cell surface triggered internalization of the complex. 13, 14 (Fig. 7a,c) taken before tail-vein injection of anti-PSMA conjugated SPIONs showed no added iron within either a DU145 tumor (Fig. 7a) or an LNCaP tumor (Fig. 7c ). An anatomical reference T 2 w MR image of the same slice through the mouse (Fig. 7b) showed the locations of the tumors. 3D surface plots (Fig. 7d,e) showed the lack of added iron within each tumor as well as the background noise before the injection of the SPIONs. After the injection of anti-PSMA conjugated SPIONs, we observed a rapid uptake of iron in only the PSMApositive LNCaP and C4-2 tumors, but essentially no uptake by the PSMA-negative DU145 tumors. For example, Figure  8a Fig. 8i ), there was still no iron uptake by this PSMA-negative tumor (See also Fig. 8g,k) . The resulting uptake of iron by the LNCaP tumor, on the other hand, was observed as early as 123 min postinjection (Fig. 8c,d ). This continued at 666 min and diminished at 1242 min (see also Fig. 8g,k) . The average [Fe] within the LNCaP tumor between 123 and 666 min postinjection was $150 lM. The The red curve represents the contrast in T 2 -w MR images; the blue curve is for T 1 -w MR images, and the green curve is the difference in contrast. These curves were calculated from the equations in Sillerud 6 using the parameters given in the Materials and Methods section. 3D surface plots also showed that the distribution of iron within the tumor was not completely uniform (Fig. 8d,h ) congruent with the optical findings (Fig. 6f) . The time course of iron uptake by both PSMAnegative DU145 and PSMA-positive C4-2 and LNCaP tumors as a result of the injection of 60-160 nmol of iron in the form of anti-PSMA conjugated SPIONs (Fig. 9) showed that the [Fe] rose, reaching a maximum within 30 min in the PSMA-positive tumors, but never rose above the background limit of detection of $2 lM for the PSMAnegative tumors. The results in Figure 9a also showed that the iron uptake by PSMA-positive tumors increased in proportion to the amount of injected iron. As controls we used, in addition to the PSMA-negative DU145 tumors, SPIONs to which no antibody was attached in both PSMApositive and PSMA-negative tumors and these results from n 5 17 measurements (the blue line in Fig. 9a ) showed that without a targeting agent directed at the tumor there was no iron uptake. The injection of larger amounts of iron, up to 1.6 lmol, did not appear to alter the [Fe] dynamics (Fig.  9b) with the maximum [Fe] occurring around 10-12 h postinjection. Even at this high dose of iron, the DU-145 tumors did not appear to sequester amounts of iron higher than the background detection limit. The iron from the injected SPIONs appeared to be metabolized by 26 h because the [Fe] MRI signals returned to essentially their preinjection values by this time (Fig. 9a,b) . Figure 10 . The uptake of iron by PSMA-positive tumors was roughly proportional to the amount injected; the slope of the line fitted to the data indicated that an injection of anti-PSMA conjugated SPIONs containing 1 lmol of iron resulted in a tumor [Fe] of 76 lM, which resulted in the delivery of $76 nmol of iron to a tumor with a volume of 1.0 mL. It is also seen in Figure 10 that even at the highest iron dose of 1.6 lmol, the PSMA-negative DU145 tumors did not nonspecifically take up iron from the anti-PSMA conjugated SPIONs in the circulation (Fig. 10 red curve) . A similar lack of nonspecific uptake was observed when the antibodies against PSMA were omitted from the injected SPION preparation (Fig.  10, red curve) .
We measured the fraction of the initial iron dose that was taken up by the PSMA-positive tumors to be 2.32 6 0.75% (n 5 10), while that for the DU145 tumors and for the SPIONs lacking anti-PSMA antibodies to be 0.16 6 0.34% (n 5 7) from which we calculated a ratio of iron uptake by PSMA 1 to PSMA-tumors of at least 15:1 (P 5 0.01).
Discussion
We have previously developed and validated a general, quantitative MRI theory for the measurement of nanoscale magnetic objects introduced into biological systems. 6 This method, which we refer to as iron concentration magnetic 
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resonance imaging, or [Fe]MRI, uses only the T 1 w and T 2 w spin-echo images available on any MRI system, and was applied here for the determination of the iron concentration in human prostate tumor xenografts after the injection of anti-PSMA-conjugated SPIONs. One potential use for these PSMA-targeted SPIONs is for the specific MR imaging and detection of prostate tumors, but it first needed to be demonstrated that these SPIONs discriminated among prostate tumors in vivo on the basis of their expression of this important cell-surface marker, as we previously found for prostate tumor cells. 6 Our primary goal then was to apply (Fig. 1c,d ) gave the closely related values of 20.21 6 0.05 and 20.88 6 0.31. The reversal of the sign of the contrast seen in the T 1 w images (Fig. 1c,e,g ) as time progressed after the SPION injection was also congruent with the theory (Fig. 2) because, as the SPIONs diffused away from the injection site, the local [Fe] decreased to $0.2 mM at 3 h where Figure 2 showed that the T 1 w contrast was zero. By 7 h post-SPION-injection, the calculations indicated that the [Fe] decreased further to $0.16 mM where the T 1 -w contrast became slightly positive at 0.24 6 0.04, while the T 2 -w contrast remained negative (-0.79 6 0.12).
These contrast changes were used to measure the SPION boundary movement into the tumor parenchyma after direct intratumoral SPION injection to give the diffusion coefficient of the SPIONs. The value found of D SPION diffusion of the SPIONs appeared to be isotropic within the tumor tissue in three separate experiments. Although the direct injection of SPIONs into tumors could be used to gather diffusion data simply from the observed boundary movement, further analysis required that the actual concentration of iron within the tumor be determined. As a guide in this direction, we used our theory of the MRI contrast which we found to correctly predict the contrast for various concentrations of iron. When applied to tumors with direct SPION injection, we could measure the actual iron concentration and follow it as a function of time in vivo. We found that we could account for greater than 90% of the injected iron be means of [Fe] MRI and that the injected iron remained within the tumor for up to 24 h. However, one of the drawbacks of our [Fe]MRI method was that the high iron concentration at the injection site could saturate the MRI response of the tissue water and render the tumor region completely black, again understandable on the basis of our calculations. Direct injection was also not particularly meaningful from a physiological point of view because drugs, such as those used for chemotherapy, are often administered intravenously.
We, therefore, undertook a series of studies of the dynamics of our anti-PSMA conjugated SPIONs using tail vein injection into the circulation. [Fe]MRI was used to quantitatively monitor the uptake and release of the SPIONs in human prostate tumor xenografts. We were aided in the discrimination of tumors based on their cellsurface expression of PSMA by the development of our dual-tumor model in which separate tumors were introduced into each flank of a nude mouse. This was particularly useful when these two tumors differed in PSMA expression, such as for the pairs DU145/LNCaP or C4-2/ DU145 where we generated both a PSMA-positive and a control, PSMA-negative tumor within the same animal. By these means, we showed that iron uptake by the tumors depended on their expression of PSMA and that the iron content of the PSMA-positive tumors reached a maximum within $30 min after tail vein injection of the SPIONs, a time that was determined by the delivery of the SPIONs to the tumors by means of the circulation and the speed with which the mice could be reimaged after injection. The [Fe] in PSMA-positive LNCaP or C4-2 tumors remained elevated for 11-12 h and then decreased so that by $24 h later it had essentially returned to preinjection levels. Numerous control experiments in which we used SPIONs that were prepared without antibodies supported this conclusion because when these were injected into the circulation of animals bearing PSMA-positive C4-2 and LNCaP tumors we observed no iron uptake in the absence of a targeting ligand. No iron uptake was observed in PSMA-negative DU145 tumors, either using anti-PSMAconjugated SPIONs or SPIONs containing no anti-PSMA antibodies.
Our Because we could measure the actual [Fe] within the tumors in real time, we were also able to determine the dose-response of tumor iron and to measure the fraction of the injected dose that was delivered to the tumors. It is interesting to note that we observed no difference in the iron uptake between LNCaP and C4-2 tumors. This was likely due to the fact that the cells in neither type of tumor would have been saturated with SPIONs because the number of PSMA molecules per tumor cell was on the order of a million while the number of SPIONs per cell was approximately 1000-fold lower; we did not administer sufficient SPIONs to saturate the cells binding sites so that the tumor iron concentration would have been solely determined by the initial dose.
Several areas of future interest for [Fe] MRI include the ability to quantitatively determine the delivery of material incorporated within nanoparticles, such as drugs, RNA, or other biological agents and to directly measure the targeting efficiency of nanoparticles in vivo. For example, our earlier studies on the treatment of prostate cancer used superparamagnetic FePt nanomicelles 19 into which chemotherapeutic drugs were bound. 3 Iron assays and HPLC were used to determine the iron to drug ratio, and by using [Fe]MRI one could potentially use the iron measurements as a surrogate in vivo for the concentration of drug delivered to the tumor. One advantage of the [Fe]MRI method is that it only shows the added iron because the background tumor signal before iron addition is subtracted out in the analysis and is, therefore, insensitive to the background tissue [Fe] . Among the many other potential applications of this method, an important one would be to measure the macrophage density in inflamed tissues by [Fe] MRI. We are currently pursuing a human clinical trial of the application of MRI of SPIONs in the diagnosis of diabetic osteomyelitis 20, 21 where large numbers of macrophages invade the tissue. We have used the fact that macrophages take up ferumoxytol (a similar SPION to the ones used here) and home to the site(s) of infection in the bone marrow to specifically image the lesions in the marrow. The macrophage density, and by inference, the severity of the infection could then be judged with the aid of [Fe] determinations in the affected tissues. Other potential applications of [Fe]MRI could be to the measurement of amyloid plaque density or microglial activation in Alzheimer's dementia, 22 or the quantitation of magnetically labeled stem cells.
23,24
The limitations of [Fe] MRI include the fact that the initial studies of prostate tumors and cells were not yet optimized so the present lower iron concentration that could be reliably measured was $2 lM. However, as we have shown for the detection of magnetic nanoparticles in Alzheimer's studies, the MRI detection parameters could be optimized 22 and that this limit of detection could probably be reduced. The upper limit on the iron concentration for the [Fe]MRI method using the MACs SPIONs was in the range 0.7-1.0 mM as determined by the reduction in the contrast change to zero. For the SPIONs used here, the MR signal would be entirely quenched at these iron concentrations. The studies reported here also used average values for the tumor T 1 and T 2 relaxation times. We have found that these vary from point to point within a tumor and among tumors by $5% so that a more accurate way of computing the [Fe] would take these individual variations into account in the theory.
In conclusion, we have shown that our novel, quantitative [Fe]MRI method can be used to determine the diffusion of SPIONs within tumors, to measure the targeting and delivery of anti-PSMA-labeled SPIONs to tumors, and to ascertain the dynamics of the [Fe] in human prostate tumor xenografts in nude mice. Furthermore, this method can be used to differentiate prostate tumor types expressing large amounts of PSMA from those that do not.
